AKBA $0.00 ( +0.00%) Quote details

stock

Akebia Ther

NASDAQ | AKBA

3.68

USD

+0.00 ( +0.00%)

AT CLOSE (AS OF Jun 25, 2025)

$964M

MARKET CAP

-

P/E Ratio

-0.21

EPS

$4.1

52 Week High

$0.91

52 Week Low

LIFE SCIENCES

Sector

AKBA Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

AKBA Technicals

Tags:

AKBA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $97M
Total Revenue $160M
Cost Of Revenue $63M
Costof Goods And Services Sold $63M
Operating Income -$50M
Selling General And Administrative $107M
Research And Development $38M
Operating Expenses $147M
Investment Income Net -
Net Interest Income -$18M
Interest Income -
Interest Expense $18M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $37M
Income Before Tax -$69M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$69M
Comprehensive Income Net Of Tax -
Ebit -$50M
Ebitda -$14M
Net Income -$69M

Revenue & Profitability

Earnings Performance

AKBA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $221M
Total Current Assets $114M
Cash And Cash Equivalents At Carrying Value $52M
Cash And Short Term Investments $52M
Inventory $16M
Current Net Receivables $34M
Total Non Current Assets $107M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill $59M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $11M
Other Non Current Assets -
Total Liabilities $270M
Total Current Liabilities $81M
Current Accounts Payable $15M
Deferred Revenue -
Current Debt -
Short Term Debt $5.4M
Total Non Current Liabilities $189M
Capital Lease Obligations $8.9M
Long Term Debt $39M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $48M
Other Current Liabilities $66M
Other Non Current Liabilities $104M
Total Shareholder Equity -$49M
Treasury Stock -
Retained Earnings -$1.7B
Common Stock $2K
Common Stock Shares Outstanding $211M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$41M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $38M
Capital Expenditures $33K
Change In Receivables -
Change In Inventory $4.2M
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $50M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$1.3M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$69M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $97M
Total Revenue $160M
Cost Of Revenue $63M
Costof Goods And Services Sold $63M
Operating Income -$50M
Selling General And Administrative $107M
Research And Development $38M
Operating Expenses $147M
Investment Income Net -
Net Interest Income -$18M
Interest Income -
Interest Expense $18M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $37M
Income Before Tax -$69M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$69M
Comprehensive Income Net Of Tax -
Ebit -$50M
Ebitda -$14M
Net Income -$69M

AKBA News

AKBA Profile

Akebia Ther Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease. The company is headquartered in Cambridge, Massachusetts.

PSTV
68.45%
$0.315
HCTI
6.45%
$0.033
GNLN
-16.85%
$0.0074
ICU
17.85%
$0.4238
NVDA
4.33%
$154.31
QS
30.95%
$5.67
DNN
-1.94%
$1.765
LCID
-1.38%
$2.14
VOR
74.28%
$0.5544
TSLA
-3.79%
$327.55
SRFM
-29.44%
$2.54
F
-2.24%
$10.49
SMCI
8.80%
$46.61
SONM
12.50%
$1.26
AMD
3.59%
$143.4
AXDX
-61.36%
$0.034
SOFI
1.45%
$16.08
BP
1.64%
$30.32
SAFX
27.11%
$2.1735
VHAI
-25.00%
$0.0004
INTC
-1.55%
$22.2
BB
12.47%
$4.87
ABEV
-3.13%
$2.325
HIMS
-3.52%
$41.44
PLTR
-0.23%
$142.9
LYT
-16.78%
$0.0982
JWN
0.08%
$24.66
BLNE
-7.04%
$1.32
PLUG
-6.03%
$1.09
CRCL
-10.72%
$198.79
WULF
-1.04%
$3.8
BTE
0.28%
$1.815
SNAP
-3.55%
$8.025
QXO
-7.23%
$21.81
AAL
-2.73%
$11.06
RIG
-2.22%
$2.64
GOOGL
0.96%
$166.77
AAPL
0.63%
$201.56
VALE
-1.63%
$9.06
HOOD
0.90%
$82.75
ONDS
0.63%
$1.6
ACHR
-7.41%
$9.935
WBD
-0.04%
$10.8958
MARA
0.71%
$14.985
MU
-0.52%
$127.25
BTG
0.84%
$3.59
ADIL
7.28%
$0.246
NVTS
-4.49%
$7.02
RIOT
-0.20%
$10
APLD
-4.84%
$9.82
ITUB
-3.02%
$6.585
CLSK
5.58%
$10.6
SOUN
-2.55%
$9.57
BAC
0.45%
$46.87
PCG
-2.61%
$13.79
NCNA
-2.21%
$0.0885
NGD
-1.62%
$4.85
AMZN
-0.37%
$211.99
DFS
-0.21%
$200.05
GRAB
-3.27%
$4.585
QBTS
-5.34%
$14.17
COIN
3.06%
$355.37
CUTR
-10.19%
$0.0969
RGTI
-3.57%
$11.09
RKLB
2.07%
$33.46
TMC
13.31%
$7.49
STLA
2.92%
$9.87
IQ
-1.69%
$1.75
WLGS
3.31%
$0.05
OSCR
-1.96%
$20.02
CCL
-0.86%
$25.48
AG
1.05%
$8.145
T
-1.20%
$27.94
NKTR
19.10%
$29.12
IREN
2.86%
$11.87
PFE
-0.21%
$24.26
BBD
-1.49%
$2.985
CAN
6.70%
$0.6495
CIFR
-0.13%
$3.845
RZLV
2.52%
$2.85
SHEL
-0.98%
$69.45
GCTK
26.25%
$7.84
ULY
82.37%
$8.19
NAAS
10.68%
$0.85
AFMD
-34.95%
$0.1815
AMCR
-1.36%
$9.055
QSI
7.45%
$2.02
GOOG
2.24%
$171.49
ASTS
-6.11%
$49.97
LDTC
-19.74%
$0.1525
RUN
1.11%
$7.28
GNS
6.17%
$0.74
NIO
-0.86%
$3.47
FLG
-3.82%
$10.695
EQX
0.77%
$5.875
RXRX
-1.15%
$5.16
MLGO
5.43%
$0.6116
HBAN
0.12%
$16.28
HAL
0.05%
$20.78
CSCO
0.44%
$68.19
PSTV
68.45%
$0.315
HCTI
6.45%
$0.033
GNLN
-16.85%
$0.0074
ICU
17.85%
$0.4238
NVDA
4.33%
$154.31
QS
30.95%
$5.67
DNN
-1.94%
$1.765
LCID
-1.38%
$2.14
VOR
74.28%
$0.5544
TSLA
-3.79%
$327.55
SRFM
-29.44%
$2.54
F
-2.24%
$10.49
SMCI
8.80%
$46.61
SONM
12.50%
$1.26
AMD
3.59%
$143.4
AXDX
-61.36%
$0.034
SOFI
1.45%
$16.08
BP
1.64%
$30.32
SAFX
27.11%
$2.1735
VHAI
-25.00%
$0.0004
INTC
-1.55%
$22.2
BB
12.47%
$4.87
ABEV
-3.13%
$2.325
HIMS
-3.52%
$41.44
PLTR
-0.23%
$142.9
LYT
-16.78%
$0.0982
JWN
0.08%
$24.66
BLNE
-7.04%
$1.32
PLUG
-6.03%
$1.09
CRCL
-10.72%
$198.79
WULF
-1.04%
$3.8
BTE
0.28%
$1.815
SNAP
-3.55%
$8.025
QXO
-7.23%
$21.81
AAL
-2.73%
$11.06
RIG
-2.22%
$2.64
GOOGL
0.96%
$166.77
AAPL
0.63%
$201.56
VALE
-1.63%
$9.06
HOOD
0.90%
$82.75
ONDS
0.63%
$1.6
ACHR
-7.41%
$9.935
WBD
-0.04%
$10.8958
MARA
0.71%
$14.985
MU
-0.52%
$127.25
BTG
0.84%
$3.59
ADIL
7.28%
$0.246
NVTS
-4.49%
$7.02
RIOT
-0.20%
$10
APLD
-4.84%
$9.82
ITUB
-3.02%
$6.585
CLSK
5.58%
$10.6
SOUN
-2.55%
$9.57
BAC
0.45%
$46.87
PCG
-2.61%
$13.79
NCNA
-2.21%
$0.0885
NGD
-1.62%
$4.85
AMZN
-0.37%
$211.99
DFS
-0.21%
$200.05
GRAB
-3.27%
$4.585
QBTS
-5.34%
$14.17
COIN
3.06%
$355.37
CUTR
-10.19%
$0.0969
RGTI
-3.57%
$11.09
RKLB
2.07%
$33.46
TMC
13.31%
$7.49
STLA
2.92%
$9.87
IQ
-1.69%
$1.75
WLGS
3.31%
$0.05
OSCR
-1.96%
$20.02
CCL
-0.86%
$25.48
AG
1.05%
$8.145
T
-1.20%
$27.94
NKTR
19.10%
$29.12
IREN
2.86%
$11.87
PFE
-0.21%
$24.26
BBD
-1.49%
$2.985
CAN
6.70%
$0.6495
CIFR
-0.13%
$3.845
RZLV
2.52%
$2.85
SHEL
-0.98%
$69.45
GCTK
26.25%
$7.84
ULY
82.37%
$8.19
NAAS
10.68%
$0.85
AFMD
-34.95%
$0.1815
AMCR
-1.36%
$9.055
QSI
7.45%
$2.02
GOOG
2.24%
$171.49
ASTS
-6.11%
$49.97
LDTC
-19.74%
$0.1525
RUN
1.11%
$7.28
GNS
6.17%
$0.74
NIO
-0.86%
$3.47
FLG
-3.82%
$10.695
EQX
0.77%
$5.875
RXRX
-1.15%
$5.16
MLGO
5.43%
$0.6116
HBAN
0.12%
$16.28
HAL
0.05%
$20.78
CSCO
0.44%
$68.19
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.